19-58085135-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145543.2(ZSCAN18):āc.1083C>Gā(p.Asp361Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,610,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001145543.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZSCAN18 | NM_001145543.2 | c.1083C>G | p.Asp361Glu | missense_variant | 7/7 | ENST00000601144.6 | NP_001139015.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZSCAN18 | ENST00000601144.6 | c.1083C>G | p.Asp361Glu | missense_variant | 7/7 | 1 | NM_001145543.2 | ENSP00000468934 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000293 AC: 7AN: 239288Hom.: 0 AF XY: 0.0000305 AC XY: 4AN XY: 130934
GnomAD4 exome AF: 0.0000343 AC: 50AN: 1457942Hom.: 0 Cov.: 32 AF XY: 0.0000345 AC XY: 25AN XY: 725138
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | The c.1251C>G (p.D417E) alteration is located in exon 7 (coding exon 7) of the ZSCAN18 gene. This alteration results from a C to G substitution at nucleotide position 1251, causing the aspartic acid (D) at amino acid position 417 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at